Contribution to the International AIDS Society Educational Fund Programme
Significant yet insufficient progress has been made in the HIV/AIDS response. The body of evidence is large and tools are available but they are not fast enough disseminated, contextualized and included into national policies and programmes. The Educational Fund addresses this by offering countries different tailor-made modules. Through Swiss support, the programme will increasingly embed HIV/AIDS into a broader health response.
Paese/Regione | Tema | Periodo | Budget |
---|---|---|---|
Mondo |
Sanità
Malattie sessualmente trasmissibili, HIV/AIDS inclusi
Salute e diritti riproduttivi Rafforzamento dei sistemi sanitari |
01.11.2018
- 30.06.2021 |
CHF 747’000
|
- Altra organizzazione svizzera non profit
-
Settore in base alle categorie del Comitato di Aiuto allo sviluppo (DAC) dell'OCSE POPULATION POLICIES/PROGRAMMES & REPRODUCTIVE HEALTH
POPULATION POLICIES/PROGRAMMES & REPRODUCTIVE HEALTH
SALUTE
Sotto-Settore in base alle categorie del Comitato di Aiuto allo sviluppo (DAC) dell'OCSE Controllo delle MST, incluso HIV/AIDS
Sanità riproduttiva
Politica sanitaria e gestione amministrativa
Temi trasversali Il progetto sostiene anche miglioramenti nell'organizzazione partner
Tipo di aiuto Contributo al progetto e al programma
Numero del progetto 7F10177
Contesto | Despite some success in addressing the AIDS epidemic, the risk of the epidemic to raise again is real, if action remains slow. Today, an estimated 37 Million people worldwide live with HIV. Just over half receive treatment. Many of those not receiving treatment don’t know their HIV status. Between 1996 and 2017, new HIV infections decreased by 47%. However, progress is stagnating, with 1.8 million new infections in 2017. Also, persistent HIV/AIDS related stigma and discrimination considerably hinders successful prevention, testing, care and treatment. |
Obiettivi | Reduction of new HIV infections and AIDS-related deaths. |
Gruppi target |
Direct target group/s: Healthcare professionals, researchers, advocates, policy makers, civil society and development partners. Ultimate target group/s: Children and men and women vulnerable to and living with HIV |
Effetti a medio termine | HIV-related public strategies and programmes, clinical practice and social support for people living with and vulnerable to HIV are revised based on the latest scientific evidence and implemented. |
Risultati |
Risultati principali attesi: Skills, knowledge and professional networks of the programme alumni (clinicians, HIV service providers, policy makers, HIV advocates, programme managers, implementers, scientists, journalists and other stakeholders in the HIV response) are enhanced. Risultati fasi precedenti: The IAS’ Educational Fund Programme disseminates and contextualizes up to date evidence and tools so as to inform policies and programmes. The Programme has so far been implemented in Nigeria, Senegal, Morocco, Brazil, Kenya, Argentina, Thailand, Côte d’Ivoire, Mexico, India and Ukraine and directly reached 2,250 stakeholders in the field of HIV/AIDS through the convening (healthcare professionals, researchers, advocates, policy makers and development partners). Several meetings resulted in formal policy recommendations and calls to action to national governments (Morocco, Kenya, Mexico, Argentina). Results depend much on a given context. Examples of results include but are not limited to increased involvement of target groups (e.g. adolescents) in designing programmes and service delivery; revised curriculum content for training of nurses; mentorship of clinical workers introduced about recent advances in HIV treatment and rolling out test and treat approaches; guidelines and programmes for new approaches (e.g. Post-Exposure Prophylaxis) developed. |
Direzione/Ufficio responsabile |
DSC |
Credito |
Cooperazione allo sviluppo |
Partner del progetto |
Partner contrattuale Organizzazione svizzera senza scopo di lucro Altri partner National partners involved in the HIV/Aids response and health more broadly (national governments, civil society, etc.) |
Coordinamento con altri progetti e attori | Pharmaceutical companies (ViiV Healthcare, Gilead Sciences),Joint UN Programme on HIV/AIDS (UNAIDS), Global Fund against AIDS, Tuberculosis and Malaria (GF) |
Budget | Fase in corso Budget Svizzera CHF 747’000 Budget svizzero attualmente già speso CHF 737’300 |
Fasi del progetto |
Fase 1 01.11.2018 - 30.06.2021 (Completed) |